Skip to main content

Ligand-defective Apolipoprotein B-100, Familial

  • Reference work entry
Encyclopedia of Molecular Mechanisms of Disease

Synonyms

Familial defective ApoB-100; FDB

Definition and Characteristics

Autosomal codominant disorder associated with hypercholesterolemia and premature coronary artery disease [1]. Clinical characteristics of FDB are tendon xanthomas and/or arcus lipoides. The disorder is caused by mutations in the LDL receptor-binding domain of apolipoprotein (apo) B-100.

Prevalence

The frequency of the most common mutation, R3500Q, is 1:300–1:500 in Caucasians. Recently, a new mutation (H3542Y) was identified with higher prevalence in patients who underwent coronary angiography compared to the R3500Q mutations (0.47% vs. 0.12%) [2].

Genes

APOB gene coding for apolipoprotein B localized on chromosome 2p24. To date, five missense mutations have been reported: R3500Q, R3500W, R3531C, R3480W, and H3543Y.

Molecular and Systemic Pathophysiology

ApoB-100 is a ligand for the low density lipoprotein (LDL) receptor and is essential for the receptor-mediated endocytosis of LDL particles. Site B (amino acid...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Innerarity TL et al. (1987) Familial defective apolipoprotein B-100: low density lipoprotein with abnormal receptor binding. Proc Natl Acad Sci USA 84:6919–6923

    PubMed  CAS  Google Scholar 

  2. Soufi M et al. (2004) A new but frequent mutation of apoB-100 – apoB His3543Tyr. Atherosclerosis 174:11–16

    PubMed  CAS  Google Scholar 

  3. Boren J et al. (2001) The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. J Biol Chem 276:9214–9218

    PubMed  CAS  Google Scholar 

  4. Schaefer JR (1997) Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs. Arterisoscl Thromb Vasc Biol 17:348–353

    CAS  Google Scholar 

  5. März W et al. (1993) Accumulation of “small dense” low density lipoproteins (LDL) in a homozygous patient with familial defective apolipoprotein B-100 results from heterogeneous interaction of LDL subfractions with the LDL receptor. J Clin Invest 92:2922–2933

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag GmbH Berlin Heidelberg

About this entry

Cite this entry

Scharnagl, H., März, W. (2009). Ligand-defective Apolipoprotein B-100, Familial. In: Lang, F. (eds) Encyclopedia of Molecular Mechanisms of Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_616

Download citation

Publish with us

Policies and ethics